4//SEC Filing
Bettinger Douglas R 4
Accession 0000707549-25-000029
CIK 0000707549other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:22 PM ET
Size
17.8 KB
Accession
0000707549-25-000029
Insider Transaction Report
Form 4
Bettinger Douglas R
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Market-based Performance Restricted Stock Unit
2025-02-04−38,000→ 0 totalExercise: $0.00→ Common Stock (38,000 underlying) - Exercise/Conversion
Common Stock
2025-02-04+21,637→ 1,011,379 total
Holdings
- 16,620
Employee Stock Option (Right to Buy)
Exercise: $59.88Exp: 2028-03-01→ Common Stock (16,620 underlying) - 39,720
Market-based Performance Restricted Stock Unit
Exercise: $0.00→ Common Stock (39,720 underlying) - 51,280
Market-based Performance Restricted Stock Unit
Exercise: $0.00→ Common Stock (51,280 underlying) - 37,980
Employee Stock Option (Right to Buy)
Exercise: $54.06Exp: 2029-03-01→ Common Stock (37,980 underlying) - 39,720
Employee Stock Option (Right to Buy)
Exercise: $98.15Exp: 2031-03-01→ Common Stock (39,720 underlying) - 11,710
Employee Stock Option (Right to Buy)
Exercise: $30.03Exp: 2027-03-02→ Common Stock (11,710 underlying) - 51,270
Employee Stock Option (Right to Buy)
Exercise: $49.09Exp: 2030-03-01→ Common Stock (51,270 underlying)
Footnotes (10)
- [F1]On 03/01/2022, the Reporting Person received a target grant of 38,000 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025.
- [F10]The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
- [F2]The amount reported includes shares subject to unvested restricted stock units.
- [F3]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025.
- [F4]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.
- [F5]The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027.
- [F6]The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024.
- [F7]The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025.
- [F8]The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.
- [F9]The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
Documents
Issuer
LAM RESEARCH CORP
CIK 0000707549
Entity typeother
Related Parties
1- filerCIK 0001469469
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:22 PM ET
- Size
- 17.8 KB